This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Qatar University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Ala-Eddin Al Moustafa
Introduction
Ala-Eddin Al Moustafa is a prominent inventor based in Doha, Qatar. He has made significant contributions to the field of cancer treatment, particularly focusing on triple negative breast cancer. With a total of 2 patents, his work is paving the way for new therapeutic options in oncology.
Latest Patents
One of Ala-Eddin Al Moustafa's latest patents is a chalcone-based chemotherapeutic compound specifically designed for the treatment of triple negative breast cancer. This patent outlines compounds, compositions, and methods that are useful in combating this aggressive form of cancer. The invention includes compounds of a specific formula, as well as pharmaceutically acceptable salts or solvates. The methods described involve administering an effective amount of these compounds or compositions to patients in need of treatment.
Career Highlights
Ala-Eddin Al Moustafa is affiliated with Qatar University, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a commitment to improving cancer treatment outcomes through scientific advancements.
Collaborations
He collaborates with notable colleagues such as Ashraf Khalil and Dana H Elkhalifa, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ala-Eddin Al Moustafa's contributions to cancer research exemplify the impact of innovation in medicine. His patents reflect a dedication to finding effective treatments for challenging health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile